Navigation Links
US WorldMeds Announces the Launch of Revonto™ (dantrolene sodium for injection)
Date:7/6/2010

LOUISVILLE, Ky., July 6 /PRNewswire/ -- US WorldMeds is proud to announce the launch of Revonto™ (dantrolene sodium for injection), the first patented scientific advancement in the treatment of malignant hyperthermia (MH).  The time to reconstitute dantrolene sodium for injection has been dramatically reduced to approximately 20 seconds or until the solution is clear.  Revonto™ retains the cost-savings of the original dantrolene sodium for injection product while offering a significant improvement in pharmacotherapy.

"The enhanced reconstitution time is an important and critical scientific improvement to intravenous dantrolene sodium, the only available antidote for the treatment of malignant hyperthermia.  MH is triggered in some patients by certain inhalation anesthetics during surgery.  A rapid response to MH onset is critical because temperatures exceeding 105F degrees and death due to this condition can occur as early as 30 minutes from onset." says Dr. George A. Digenis, Chief Scientific Officer of US WorldMeds.

Fatal and non-fatal liver disorders of an idiosyncratic or hypersensitivity type may occur with dantrolene sodium therapy.  There have been reports of thrombophlebitis following administration of intravenous dantrolene.  There have been rare reports of urticaria and erythema possibly associated with the administration of i.v. dantrolene sodium. For additional information, including the full prescribing information for Revonto™, please visit US WorldMeds' website at www.revonto.com.

For more information on malignant hyperthermia, please visit The Malignant Hyperthermia Association of the United States (MHAUS) website at www.mhaus.org

Revonto™ will be available on GPO contracts as a dropship via your wholesaler/distributor.

For Ordering Information Call: 1.877.411.USWM(8796).

About US WorldMeds

US WorldMeds, LLC, a specialty pharmaceutical company located in Louisville, Kentucky, is committed to developing, licensing, and marketing unique and significant pharmaceuticals that address unmet medical needs. US WorldMeds is committed to using science to make lives better. For more information, please visit www.usworldmeds.com


'/>"/>
SOURCE US WorldMeds
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bionovo Announces a $15 Million At-The-Market Firm Commitment Financing Agreement
2. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Second Quarter 2010 Results
3. Fougera® Announces First Generic Approval of Adapalene Cream 0.1% (Rx), Equivalent to Differin®
4. Biodel Announces Schedule for Presentations at the 37th Annual Meeting and Exposition of the Controlled Release Society
5. PolyTouch Medical Ltd. Announces the Appointment of Robert D. Fanelli, MD, FACS, FASGE as Medical Advisor
6. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant Human Stem Cells
7. ProUroCare Medical Announces Offering of Replacement Warrants in Exchange for Early Exercise of Outstanding Warrants
8. MiMedx Group, Inc. Announces Release Date for Second Quarter Results
9. Aeras Global TB Vaccine Foundation Announces Appointment of Accomplished Pharmaceutical Executive as President and CEO
10. Jiangbo Pharmaceuticals Announces the Appointment of New Chief Executive Officer
11. Sysmex America Announces Executive Leadership Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... 6, 2016  Nearly 30 million people in ... epidemic of diabetes. 1 However, nearly 40% of ... levels (hyperglycemia) and significant glucose variability. 2 These patients ... cardiovascular events. If left untreated, hyperglycemia can lead to ... or blindness. 3 As part of ...
(Date:12/6/2016)... Miss. , Dec. 6, 2016 Two ... rescue personnel in a simulated mass casualty event Tuesday ... . The technology debuted before an audience including ... and representatives from Homeland Security, Federal Law Enforcement ... Drone Project, known as HiRO (Health Integrated Rescue Operations), ...
(Date:12/6/2016)... JUPITER, Fla. , Dec. 6, 2016 With opioids ... a newcomer in the prescription drug market that has led to ... is approximately seven to eight times stronger than heroin or morphine, ... ... Suzanne Smolkin , vice president, clinical operations, Behavioral Health for ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... , ... “Fred Rides a Train” allows readers to tag along on a ... a Train” is the creation of published author, Janet Morrison, who has been writing ... The "Fred, the Dog" series is her first attempt at writing for children. Janet, ...
(Date:12/7/2016)... San Mateo, CA (PRWEB) , ... December 07, 2016 , ... ... entire San Francisco Peninsula region, is proud to announce new city-specific pages as part ... care services for the elderly, they often look, first, for local agencies serving their ...
(Date:12/6/2016)... , ... December 06, 2016 , ... ... dysfunction because of a higher risk of serious health problems, such as cardiovascular ... Star2.com. Dr. Peiman Soleymani of Beverly Hills Periodontics & Dental Implant Center notes ...
(Date:12/6/2016)... California (PRWEB) , ... December 06, 2016 , ... ... management (PHM) technology, has named Ajdin Camaga as a vice president of sales. ... says Justin Neece, president. “He works hard to understand what each client needs, ...
(Date:12/6/2016)... ... December 06, 2016 , ... In anticipation for the New ... the availability of continuing education courses in 2017, dentists of all levels can continue ... Beginning in January, dentists can attend a variety of continuing education courses each month ...
Breaking Medicine News(10 mins):